Actively Recruiting
Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
Led by Anhui Provincial Hospital · Updated on 2025-02-11
150
Participants Needed
1
Research Sites
116 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to compare 5.0T and 3.0T biparametric magnetic resonance imaging in the diagnosis of prostate cancer. The main aims of this study are: * Compare the diagnostic efficacy of 5.0TbpMRI and 3.0TbpMRI for prostate cancer. Preliminarily evaluate the value of 5.0TbpMRI in diagnosing prostate cancer. * Compare and analyze the accuracy of 5.0TbpMRI and 3.0TbpMRI in determining the T stage of prostate cancer. Preliminary evaluation of the value of 5.0TbpMRI in determining the tumor stage of prostate cancer. The data of participants was collected prospectively.
CONDITIONS
Official Title
Comparison of 5.0T and 3.0T Biparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- The patient has at least one indication for prostate biopsy (Chinese expert consensus on prostate biopsy (2022 edition))
- The patient has no other cancer history besides primary prostate cancer
- The patient completed a 3.0T biparametric MRI with clear and accessible images
- The patient completed a 5.0T biparametric MRI with clear and accessible images
- The patient understands the study and voluntarily signs informed consent
You will not qualify if you...
- The patient has contraindications to MRI such as metal plates or heart stents
- The patient has no indication for prostate biopsy or refuses biopsy
- The patient has contraindications to prostate biopsy
- The 3.0T MRI shows multiple lymph node or bone metastases
- The patient has had other prostate surgery in the past
- The patient is unable to cooperate, has communication barriers, or refuses to sign informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department of Urology, The First Affiliated Hospital of USTC
Hefei, Anhui, China, 230001
Actively Recruiting
Research Team
C
Changming Wang, M.D.
CONTACT
J
Jun Xiao, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here